drugset / Trial / NCT00006079

Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

NCT00006079

RandomizedSingle-groupTriple-blindPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of eflornithine may be an effective way to prevent the recurrence of or further development of cervical cancer. PURPOSE: Randomized phase II trial to determine the effectiveness of eflornithine in preventing cervical cancer in patients who have cervical intraepithelial neoplasia.

Timeline

Start
1998-06-19
Primary completion
2004-04-27
Completion
2004-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Eflornithine Small molecule Oral